{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:47Z","timestamp":1792787927488,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA47888"],"award-info":[{"award-number":["T32 CA47888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA47888"],"award-info":[{"award-number":["T32 CA47888"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"O\u2019Neal Invests Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) primarily affects older adults and has a poor prognosis. Although tools like geriatric assessments and electronic patient-reported outcomes (ePRO) can guide treatment, they are underutilized in clinical practice. This secondary analysis of the INSPIRE pilot intervention, a pilot intervention that assessed the utility of incorporating data on patient preferences and frailty into multidisciplinary tumor board (MDTB) discussions, evaluated the clinical impact of incorporating patient preferences and frailty data into MDTB discussions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study included patients aged\u2009\u2265\u200960 years with PDAC enrolled in the INSPIRE intervention at the University of Alabama at Birmingham. Patients discussed at MDTBs with adequate medical records who did not forgo treatment initially were included. A control group comprised patients who completed preference and frailty surveys but whose ePRO data were not presented at MDTBs. Outcomes analyzed included treatment consistency with preferred National Comprehensive Cancer Network (NCCN) regimens based on fitness, unplanned treatment modifications, and healthcare utilization within six months of treatment initiation. Data were extracted from medical records and statistical analysis employed log-rank tests from cumulative incidence functions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 121 patients (24 intervention, 97 controls), the median age was 70 years. Compared to controls, the intervention group had fewer comorbidities (8% vs. 25% with no comorbidities, V\u2009=\u20090.22), a higher proportion of non-White patients (42% vs. 25%, V\u2009=\u20090.15), more resectable disease (48% vs. 35%, V\u2009=\u20090.14), and higher frailty rates (42% vs. 31%, V\u2009=\u20090.11). Intervention patients showed slightly higher consistency with NCCN preferred regimens based on fitness (63% vs. 60%, V\u2009=\u20090.02), fewer unplanned treatment modifications (54% vs. 68%, V\u2009=\u20090.12), and lower hospital admissions (33% vs. 50%, V\u2009=\u20090.13).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The INSPIRE intervention demonstrated promising signals when aligning treatment regimens with patient capabilities and preferences, potentially reducing unplanned treatment modifications and hospital admissions. Larger studies are needed to confirm these exploratory results and assess broader applicability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-14847-w","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:46:00Z","timestamp":1767062760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of electronic patient-reported outcomes (ePRO) presentation in pancreatic cancer tumor board discussions on cancer outcomes: the INSPIRE intervention"],"prefix":"10.1186","volume":"26","author":[{"given":"Garrett","family":"Bourne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joud","family":"El Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney P.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Pywell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Bart","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Qasim Hussaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Nipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Rocque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"14847_CR1","unstructured":"Cancer of the Pancreas - Cancer Stat Facts. SEER. Accessed July 9. 2025. https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html"},{"issue":"9","key":"14847_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM. Pancreatic cancer: A review. JAMA. 2021;326(9):851\u201362. https:\/\/doi.org\/10.1001\/jama.2021.13027.","journal-title":"JAMA"},{"issue":"15","key":"14847_CR3","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1002\/cncr.32961","volume":"126","author":"CP Williams","year":"2020","unstructured":"Williams CP, Miller-Sonet E, Nipp RD, Kamal AH, Love S, Rocque GB. Importance of quality-of-life priorities and preferences surrounding treatment decision making in patients with cancer and oncology clinicians. Cancer. 2020;126(15):3534\u201341. https:\/\/doi.org\/10.1002\/cncr.32961.","journal-title":"Cancer"},{"issue":"5","key":"14847_CR4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/SLA.0000000000006053","volume":"279","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zironda A, Vierkant RA, et al. Quality of life and Gastrointestinal symptoms in Long-term survivors of pancreatic cancer following pancreatoduodenectomy. Ann Surg. 2024;279(5):842\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000006053.","journal-title":"Ann Surg"},{"issue":"5","key":"14847_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.hpb.2024.02.011","volume":"26","author":"EA Joseph","year":"2024","unstructured":"Joseph EA, Bowers KD, Marcus R, et al. Assessing the long-term priorities of pancreaticoduodenectomy survivors. HPB. 2024;26(5):703\u201310. https:\/\/doi.org\/10.1016\/j.hpb.2024.02.011.","journal-title":"HPB"},{"issue":"2","key":"14847_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/jso.27871","volume":"131","author":"H Muaddi","year":"2025","unstructured":"Muaddi H, Zironda A, Zhang C, et al. Financial toxicity of Long-Term survivors who underwent pancreatoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol. 2025;131(2):232\u201341. https:\/\/doi.org\/10.1002\/jso.27871.","journal-title":"J Surg Oncol"},{"issue":"8","key":"14847_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.6004\/jnccn.2020.7548","volume":"18","author":"M Guan","year":"2020","unstructured":"Guan M, Gresham G, Shinde A, et al. Priority rankings of patient-Reported outcomes for pancreatic ductal adenocarcinoma: A comparison of patient and physician perspectives. J Natl Compr Cancer Netw JNCCN. 2020;18(8):1075\u201383. https:\/\/doi.org\/10.6004\/jnccn.2020.7548.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"14847_CR8","doi-asserted-by":"publisher","unstructured":"West H (Jack), Jin JO, editors. Performance Status in Patients With Cancer. JAMA Oncol. 2015;1(7):998. https:\/\/doi.org\/10.1001\/jamaoncol.2015.3113","DOI":"10.1001\/jamaoncol.2015.3113"},{"key":"14847_CR9","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3332\/ecancer.2019.913","volume":"13","author":"SS Datta","year":"2019","unstructured":"Datta SS, Ghosal N, Daruvala R, et al. How do clinicians rate patient\u2019s performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology. Ecancermedicalscience. 2019;13:913. https:\/\/doi.org\/10.3332\/ecancer.2019.913.","journal-title":"Ecancermedicalscience"},{"issue":"6","key":"14847_CR10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.jpainsymman.2018.02.015","volume":"55","author":"G Popovic","year":"2018","unstructured":"Popovic G, Harhara T, Pope A, et al. Patient-Reported functional status in outpatients with advanced cancer: correlation with Physician-Reported scores and survival. J Pain Symptom Manage. 2018;55(6):1500\u20138. https:\/\/doi.org\/10.1016\/j.jpainsymman.2018.02.015.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"14847_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cncr.33238","volume":"127","author":"CD Bergerot","year":"2021","unstructured":"Bergerot CD, Philip EJ, Bergerot PG, et al. Discrepancies between genitourinary cancer patients\u2019 and clinicians\u2019 characterization of the Eastern cooperative oncology group performance status. Cancer. 2021;127(3):354\u20138. https:\/\/doi.org\/10.1002\/cncr.33238.","journal-title":"Cancer"},{"issue":"1","key":"14847_CR12","first-page":"48","volume":"83","author":"B Elsawy","year":"2011","unstructured":"Elsawy B, Higgins KE. The geriatric assessment. Am Fam Physician. 2011;83(1):48\u201356.","journal-title":"Am Fam Physician"},{"issue":"2","key":"14847_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/jamaoncol.2019.4728","volume":"6","author":"SG Mohile","year":"2020","unstructured":"Mohile SG, Epstein RM, Hurria A, et al. Communication with older patients with cancer using geriatric assessment: A Cluster-Randomized clinical trial from the National cancer Institute community oncology research program. JAMA Oncol. 2020;6(2):196\u2013204. https:\/\/doi.org\/10.1001\/jamaoncol.2019.4728.","journal-title":"JAMA Oncol"},{"issue":"2","key":"14847_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jgo.2019.08.005","volume":"11","author":"C DuMontier","year":"2020","unstructured":"DuMontier C, Sedrak MS, Soo WK, et al. Arti Hurria and the progress in integrating the geriatric assessment into oncology: young international society of geriatric oncology review paper. J Geriatr Oncol. 2020;11(2):203\u201311. https:\/\/doi.org\/10.1016\/j.jgo.2019.08.005.","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"14847_CR15","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jgo.2020.07.009","volume":"11","author":"S Giri","year":"2020","unstructured":"Giri S, Chakiba C, Shih YY, et al. Integration of geriatric assessment into routine oncologic care and advances in geriatric oncology: A young international society of geriatric oncology report of the 2020 American society of clinical oncology (ASCO) annual meeting. J Geriatr Oncol. 2020;11(8):1324\u20138. https:\/\/doi.org\/10.1016\/j.jgo.2020.07.009.","journal-title":"J Geriatr Oncol"},{"issue":"33","key":"14847_CR16","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1200\/JCO.2016.67.5926","volume":"34","author":"A Gajra","year":"2016","unstructured":"Gajra A, Loh KP, Hurria A, et al. Comprehensive geriatric Assessment-Guided therapy does improve outcomes of older patients with advanced lung cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2016;34(33):4047\u20138. https:\/\/doi.org\/10.1200\/JCO.2016.67.5926.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"14847_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1200\/OP.20.00442","volume":"17","author":"W Dale","year":"2021","unstructured":"Dale W, Williams GR, MacKenzie R. How is geriatric assessment used in clinical practice for older adults with cancer?? A survey of cancer? providers by the American society of clinical oncology. JCO Oncol Pract. 2021;17(6):336\u201344. https:\/\/doi.org\/10.1200\/OP.20.00442.","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"14847_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jgo.2019.04.008","volume":"11","author":"GR Williams","year":"2020","unstructured":"Williams GR, Kenzik KM, Parman M, et al. Integrating geriatric assessment into routine Gastrointestinal (GI) consultation: the cancer and aging resilience evaluation (CARE). J Geriatr Oncol. 2020;11(2):270\u20133. https:\/\/doi.org\/10.1016\/j.jgo.2019.04.008.","journal-title":"J Geriatr Oncol"},{"issue":"22","key":"14847_CR19","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Dale W, Somerfield MR, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol. 2018;36(22):2326\u201347. https:\/\/doi.org\/10.1200\/JCO.2018.78.8687.","journal-title":"J Clin Oncol"},{"issue":"9","key":"14847_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.jval.2024.05.020","volume":"27","author":"AS Huberts","year":"2024","unstructured":"Huberts AS, Koppert LB, Benschop JAM, et al. Facilitators and barriers in the implementation and adoption of Patient-Reported outcomes measurements in daily practice. Value Health J Int Soc Pharmacoeconomics Outcomes Res. 2024;27(9):1235\u201342. https:\/\/doi.org\/10.1016\/j.jval.2024.05.020.","journal-title":"Value Health J Int Soc Pharmacoeconomics Outcomes Res"},{"issue":"26","key":"14847_CR21","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.23.00933","volume":"41","author":"W Dale","year":"2023","unstructured":"Dale W, Klepin HD, Williams GR, et al. Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update. J Clin Oncol Off J Am Soc Clin Oncol. 2023;41(26):4293\u2013312. https:\/\/doi.org\/10.1200\/JCO.23.00933.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"14847_CR22","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.clon.2021.04.008","volume":"33","author":"SE Appleyard","year":"2021","unstructured":"Appleyard SE, Larkin MJW, Stewart EM, Minton O, Gilbert DC. Digital medicine in men with advanced prostate Cancer - A feasibility study of electronic Patient-reported outcomes in patients on systemic treatment. Clin Oncol R Coll Radiol G B. 2021;33(12):751\u201360. https:\/\/doi.org\/10.1016\/j.clon.2021.04.008.","journal-title":"Clin Oncol R Coll Radiol G B"},{"issue":"9","key":"14847_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.6004\/jnccn.2024.7052","volume":"22","author":"NL Henderson","year":"2024","unstructured":"Henderson NL, Ortiz-Olguin E, Bourne G, et al. Implementation of ePROs into multidisciplinary tumor board discussions for patients with pancreatic cancer: the INSPIRE intervention. J Natl Compr Cancer Netw JNCCN. 2024;22(9):602\u20139. https:\/\/doi.org\/10.6004\/jnccn.2024.7052.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"8","key":"14847_CR24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1200\/JOP.2017.023846","volume":"13","author":"GB Rocque","year":"2017","unstructured":"Rocque GB, Cadden A. Creation of Institute of medicine care plans with an eye on Up-Front care. J Oncol Pract. 2017;13(8):512\u20134. https:\/\/doi.org\/10.1200\/JOP.2017.023846.","journal-title":"J Oncol Pract"},{"issue":"8","key":"14847_CR25","doi-asserted-by":"publisher","first-page":"101644","DOI":"10.1016\/j.jgo.2023.101644","volume":"14","author":"C Harmon","year":"2023","unstructured":"Harmon C, Fowler M, Giri S, et al. Implementation of the Web-Enabled cancer & aging resilience evaluation (WeCARE) in an outpatient oncology setting. J Geriatr Oncol. 2023;14(8):101644. https:\/\/doi.org\/10.1016\/j.jgo.2023.101644.","journal-title":"J Geriatr Oncol"},{"key":"14847_CR26","unstructured":"Guidelines Detail, Accessed NCCN. September 3, 2021. https:\/\/www.nccn.org\/guidelines\/guidelines-detail"},{"issue":"sup1","key":"14847_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00031305.2019.1583913","volume":"73","author":"RL Wasserstein","year":"2019","unstructured":"Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond p\u2009<\u20090.05. Am Stat. 2019;73(sup1):1\u201319. https:\/\/doi.org\/10.1080\/00031305.2019.1583913.","journal-title":"Am Stat"},{"issue":"2","key":"14847_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","volume":"70","author":"RL Wasserstein","year":"2016","unstructured":"Wasserstein RL, Lazar NA. The ASA statement on p-Values: context, process, and purpose. Am Stat. 2016;70(2):129\u201333. https:\/\/doi.org\/10.1080\/00031305.2016.1154108.","journal-title":"Am Stat"},{"issue":"18suppl","key":"14847_CR29","doi-asserted-by":"publisher","first-page":"LBA10003","DOI":"10.1200\/JCO.2018.36.18_suppl.LBA10003","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Epstein RM, Hurria A, et al. Improving communication with older patients with cancer using geriatric assessment (GA): A university of Rochester NCI community oncology research program (NCORP) cluster randomized controlled trial (CRCT). J Clin Oncol. 2018;36(18suppl):LBA10003\u201310003. https:\/\/doi.org\/10.1200\/JCO.2018.36.18_suppl.LBA10003.","journal-title":"J Clin Oncol"},{"issue":"18","key":"14847_CR30","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1002\/cncr.31581","volume":"124","author":"C Kenis","year":"2018","unstructured":"Kenis C, Baitar A, Decoster L, et al. The added value of geriatric screening and assessment for predicting overall survival in older patients with cancer. Cancer. 2018;124(18):3753\u201363. https:\/\/doi.org\/10.1002\/cncr.31581.","journal-title":"Cancer"},{"issue":"3","key":"14847_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1463-1318.2008.01580.x","volume":"11","author":"E MacDermid","year":"2009","unstructured":"MacDermid E, Hooton G, MacDonald M, et al. Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis Off J Assoc Coloproctology G B Irel. 2009;11(3):291\u20135. https:\/\/doi.org\/10.1111\/j.1463-1318.2008.01580.x.","journal-title":"Colorectal Dis Off J Assoc Coloproctology G B Irel"},{"issue":"8","key":"14847_CR32","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.jgo.2021.03.004","volume":"12","author":"G Rocque","year":"2021","unstructured":"Rocque G, Wheeler S, Williams GR. The missing voice in multidisciplinary tumor boards. J Geriatr Oncol. 2021;12(8):1157\u20138. https:\/\/doi.org\/10.1016\/j.jgo.2021.03.004.","journal-title":"J Geriatr Oncol"},{"issue":"16suppl","key":"14847_CR33","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1200\/JCO.2023.41.16_suppl.4158","volume":"41","author":"SH Patel","year":"2023","unstructured":"Patel SH, Colby S, Sohal D, et al. Chemotherapy dose density and effect on prognosis for patients with resectable pancreas cancer: A secondary analysis of SWOG S1505. J Clin Oncol. 2023;41(16suppl):4158\u20134158. https:\/\/doi.org\/10.1200\/JCO.2023.41.16_suppl.4158.","journal-title":"J Clin Oncol"},{"issue":"2","key":"14847_CR34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10620-023-08207-6","volume":"69","author":"N Khalaf","year":"2024","unstructured":"Khalaf N, Ali B, Liu Y, et al. Emergency presentations predict worse outcomes among patients with pancreatic cancer. Dig Dis Sci. 2024;69(2):603\u201314. https:\/\/doi.org\/10.1007\/s10620-023-08207-6.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"14847_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00280-021-04267-5","volume":"88","author":"S Mori","year":"2021","unstructured":"Mori S, Aoki T, Sakuraoka Y, et al. Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma. Cancer Chemother Pharmacol. 2021;88(1):109\u201320. https:\/\/doi.org\/10.1007\/s00280-021-04267-5.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"14847_CR36","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/000313481908501136","volume":"85","author":"H Aziz","year":"2019","unstructured":"Aziz H, Zeeshan M, Jie T, Maegawa FB. Neoadjuvant chemoradiation therapy is associated with adverse outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer. Am Surg. 2019;85(11):1276\u201380.","journal-title":"Am Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14847-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14847-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:56:25Z","timestamp":1770202585000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-14847-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14847"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14847-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"24 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approved by the UAB Institutional Review Board (IRB-300007868) and adhered to the Declaration of Helsinki. INSPIRE intervention patients provided verbal informed consent for participation. A waiver of consent was granted for historical control patients due to the absence of direct interaction and the study\u2019s reliance solely on data review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GB: none NLH: none; LD: none; JF: none; CPW: Research:GB: none NLH: none; LD: none; JF: none; CPW: Research:\u00a0flatiron; CP: none; JBR: none; GRW: Takeda, Cardinal Health; QH: none; RN: none; GR: Pfizer,\u00a0Genentech, Daiichi Sankyo, Atlas Oncology Partners, Gilead.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}